By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
PROFILE PD
Summary
What it measures:
Used to measure Parkinson disease progression and monitor response to treatment.Target Population:
People with Parkinson disease (PD); Mild/Early, Moderate/Middle, Severe/Late stagesTest description:
- Uses combination of patient self-report and physical examination
- Contains questions related to underlying impairments (11 items), activities of daily living (ADLs) (10 items), and cognition/affect (3 items)
- Each item scored on a 0-4 ordinal scale, with higher scores representing greater severity (0=no problem, 4=an important issue to the patient)
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: January 22, 2013
Contact: practice@apta.org
Content Type: Test & Measure
You Might Also Like...
Clinical Summary
Parkinson Disease (PD)Jun 25, 2024
People with PD need to develop long-term exercise habits—and be committed to participating in their intervention programs—to sustain the benefits of the
CPG
Telerehabilitation in Physical Therapist Practice: A Clinical Practice Guideline From the American Physical Therapy AssociationMar 21, 2024
The guideline provides 7 recommendations that address the impact of, preparation for, and implementation of telerehabilitation in physical therapist practice.
CPG
APTA: Physical Therapist Management of Parkinson Disease Clinical Practice Guideline (CPG+)Apr 1, 2022
Related Resources Parkinson Disease CPG Toolkit Pocket Guide Podcast: Parkinson CPG Knowledge Translation CPG+ Appraisal Rating 6 out of 7 (How was this